CU20090081A7 - CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE - Google Patents

CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE

Info

Publication number
CU20090081A7
CU20090081A7 CU20090081A CU20090081A CU20090081A7 CU 20090081 A7 CU20090081 A7 CU 20090081A7 CU 20090081 A CU20090081 A CU 20090081A CU 20090081 A CU20090081 A CU 20090081A CU 20090081 A7 CU20090081 A7 CU 20090081A7
Authority
CU
Cuba
Prior art keywords
methyl
quinolin
propionitrile
dihydro
oxo
Prior art date
Application number
CU20090081A
Other languages
Spanish (es)
Inventor
Sudhakar Devidasrao Garad
Markus Banziger
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority to CU20090081A priority Critical patent/CU20090081A7/en
Publication of CU20090081A7 publication Critical patent/CU20090081A7/en

Links

Abstract

La invención se refiere a formas cristalinas particulares del 2-metil-2-[4-(3-metil-2-oxo-8-quinolin-3-il-2,3-dihidro-imidazol-[4,5-c]-quinolin-1-il)-fenil]-propionitrilo, sus hidratos y solvatos, sus sales e hidratos y solvatos de sus sales, a ciertos procesos para su preparación, a composiciones farmacéuticas que contienen estas formas cristalinas, y a su uso en métodos de diagnóstico o, de preferencia, para el tratamiento terapéutico de animales de sangre caliente, en especial seres humanos, y a su uso como un intermediario o para la preparación de las preparaciones farmacéuticas para utilizarse en métodos de diagnóstico o, de preferencia, para el tratamiento terapéutico de animales de sangre caliente, en especial seres humanos.The invention relates to particular crystalline forms of 2-methyl-2- [4- (3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazol- [4,5-c] -quinolin-1-yl) -phenyl] -propionitrile, its hydrates and solvates, its salts and hydrates and solvates of its salts, certain processes for its preparation, pharmaceutical compositions containing these crystalline forms, and their use in methods of diagnosis or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and for use as an intermediary or for the preparation of pharmaceutical preparations for use in diagnostic methods or, preferably, for therapeutic treatment of warm-blooded animals, especially humans.

CU20090081A 2009-05-13 2009-05-13 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE CU20090081A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20090081A CU20090081A7 (en) 2009-05-13 2009-05-13 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20090081A CU20090081A7 (en) 2009-05-13 2009-05-13 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE

Publications (1)

Publication Number Publication Date
CU20090081A7 true CU20090081A7 (en) 2011-07-11

Family

ID=44306215

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090081A CU20090081A7 (en) 2009-05-13 2009-05-13 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE

Country Status (1)

Country Link
CU (1) CU20090081A7 (en)

Similar Documents

Publication Publication Date Title
ECSP099340A (en) CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -Phenyl] -PROPIONITRILE
CO2020007218A2 (en) New benzylamino-substituted pyridopyrimidinones and derivatives as sos1 inhibitors
ECSP088217A (en) FORMS OF CRYSTAL DELTA AND EYESILON MESILATE IMATINIB
DOP2016000281A (en) IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE TO TREAT CANCER
CO6400220A2 (en) SULFONAMIDE DERIVATIVES
CL2018001146A1 (en) Imidazo [4,5-c] quinolin-2-one compounds and their use in cancer treatment
UY35369A (en) Quinazolinic inhibitors of mutated epidermal growth factor receptor activating forms
UY29964A1 (en) CRYSTAL FORMS F, G, H, I, AND K OF THE IMATINIB MESILATE
ECSP11011113A (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
SV2007002813A (en) COMPOUNDS FOR THE MODULATION OF THE ACTIVITY OF THE C-FMS AND / OR THE C-KIT AND ITS APPLICABLE USES
DOP2018000115A (en) IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE IN CANCER TREATMENT
CL2012003281A1 (en) Use of specific sgc stimulating and / or activating compounds; pharmaceutical formulation comprising said compounds; kit comprising the compounds, and use for the prevention and / or treatment of systematic sclerosis.
CO6501189A2 (en) DERIVATIVES OF OXAZINE AND ITS USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
CL2017000432A1 (en) Cathepsin c spirocyclic inhibitors
CR20160537A (en) 3-QUINASA DELTA PHOSFOINOSYTI INHIBITOR FOR MEDICAL USE
ECSP14013215A (en) NEW COMPOUNDS
UY36145A (en) Compounds of 1, 3, 4-thiadiazole and use thereof for the treatment of cancer
DOP2017000018A (en) [1,2,4] TRIAZOLO [4,3-B] PIRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
CO7151509A2 (en) Difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls as bace1 inhibitors
DOP2017000244A (en) USEFUL PIRAZOL DERIVATIVES AS INHIBITORS OF 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP)
AR104068A1 (en) COMBINATIONS OF A 3-KINASE PHOSFOINOSYTIDE INHIBITOR COMPOSITE AND A CDK4 / 6 INHIBITOR COMPOUND FOR CANCER TREATMENT
CL2012002823A1 (en) Pharmaceutical composition for the treatment of diabetes and related disorders, comprising an insulin sensitizer selected from pioglitazone and rosiglitazone, glimepiride and metmorphine; oral pharmaceutical formulation that comprises it; kit to treat type II diabetes; and use of said formulation to treat diabetes.
UY31805A (en) AGONISTS M1, PHARMACEUTICAL COMPOSITIONS OF THE SAME, PROCESSES FOR THEIR PREPARATION AND ITS USES FOR THE TREATMENT OF PAIN
CU20090081A7 (en) CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE
CL2016003230A1 (en) Compounds, pharmaceutical composition and its use in the treatment of neurodegenerative diseases